ProteoThera, Inc. Receives Allowance for a Broad U.S. Patent Covering Matrix-Binding Technology Platform
09 mai 2016 08h00 HE | ProteoThera, Inc.
Newton, MA, May 09, 2016 (GLOBE NEWSWIRE) -- ProteoThera, Inc., a biotechnology company with a platform technology for local, targeted drug delivery, announced today that a notice of allowance has...